Exploring Trauma Plus (ET+) (ET+)

November 13, 2026 updated by: Envisioning Justice Solutions, Inc

Exploring Trauma Plus (ET+): A Brief Intervention for Men and Gender-Diverse Populations

This randomized controlled trial evaluates Exploring Trauma Plus (ET+), a brief, manualized, trauma-specific intervention designed for justice-involved men and transgender and gender-diverse individuals. The six-session curriculum uses psychoeducation, cognitive-behavioral strategies, mindfulness, grounding techniques, and structured exercises to help participants understand trauma, manage trauma-related distress, and develop coping skills.

The study is beging conducted at a California correctional facility for men and compares participants randomly assigned to ET+ with participants assigned to a waitlist control condition. The program is delivered by trained peer facilitators in general institutional housing on a custody level III yard.

Researchers assess changes in trauma-related distress, behavioral health symptoms, anger, and aggression using validated self-report measures administered before and after the intervention period.

Study Overview

Detailed Description

The primary objective of the randomized controlled trial is to assess the effectiveness of the Exploring Trauma Plus (ET+) curriculum at reducing co-occurring trauma, anger, and aggression among men and the transgender and gender-diverse (TGD) community. Using a randomized experimental design, this study aims to quantitatively measure change on specifically targeted outcome measures over time spent in the ET+ program among a group of males and TGD individuals who participate in the program (treatment group) versus a group of similar males and TGD individuals who did not participate in the program (control group). Refined inferential statistical analyses will be employed to analyze the data collected and explore an integrated model of trajectories of trauma and aggression among participants in prison.

ET+ is a 6-week 6-session trauma-informed program that utilizes Peer Facilitators. Peer facilitators are individuals serving long-term sentences who volunteered for these positions and were specially trained to facilitate the program for other institutional residents who participate in the program.

Institutional Review Board (IRB) approval was received on May 23, 2024. CDCR Research Oversight Committee approvals and Data Sharing Agreements were sought and also approved. Oversight will continue throughout the duration of the study.

Researchers will use a randomization design to test the effectiveness of the ET+ curriculum to reduce trauma-related difficulties (i.e., mental health symptoms, trauma, anger, hostility and aggression) and to increase Restorative Justice outcome measures (i.e., resilience, social connectedness, empathy, and accountability for the harm that has been produced).

Measured outcomes will include PTSD symptoms (Trauma Symptoms Checklist [TSC-40] and the Short Screening Scale for DSM-IV PTSD), depression (Patient Health Questionnaire - Depression Subscale), anxiety (Patient Health Questionnaire - Anxiety), aggression (Buss-Warren Aggression Questionnaire), mental health functioning (K6 Brief Mental Health Screen), instrumental and expressive anger (Revised Instrumental and Expressive Representation Scales), the Brief Resilient Coping Scale, and the Dickman Impulsivity Scale.

Study Type

Interventional

Enrollment (Estimated)

250

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • California
      • Corcoran, California, United States, 93212

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria: All participants who expressed interest in participating in the study at the California men's prison and who were capable of providing written informed consent.

-

Exclusion Criteria: There were no study-defined exclusion criteria; operational exclusions or security restrictions were at the discretion of prison administration.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Exploring Trauma Plus Brief Intervention

This revised evidence-based six-session trauma intervention is designed for people who have experienced abuse and trauma. The understanding of gender has shifted from the binary male-female model to a more inclusive and expansive model. This second edition of Exploring Trauma is now entitled Exploring Trauma+: A Brief Intervention for Men and Gender-Diverse People in order to reflect the changes in this new edition. The definition of gender responsiveness has been expanded to include the experiences of transgender and nonbinary people. This new material has inclusive pronouns, as well as examples of traumatic events and focus questions specific to this group. The materials focus on the three core things that both staff and clients need: an understanding of what trauma is, its process, and its impact on both the inner self (thoughts, feelings, beliefs, values) and the outer self (behavior and relationships).

ET+ is an evidence-based 6-session brief intervention with a focus on trauma and PTSD, and techniques for Restorative Justice work with men (and those who identify as men). The rigorously evaluated manualized curriculum is designed for trauma treatment while emphasizing Restorative Justice principles and objectives, e.g., understanding victim impact, personal accountability, and restitution. The intervention is delivered to small groups of 10-12 men and co-led by two specially trained Peer Facilitators. Using a closed group model creates the experience of a prosocial support system based on a new value system and group agreements. This is strengthened by using Peer Facilitators as role models. The group process helps develop empathy and connectedness for other group members.

No Intervention: Waitlist Control Group

Participants assigned to the waitlist control condition, serving as the comparison group during the study. Participants are offered Exploring Trauma Plus (ET+) after their study participation.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Modified Short Screening Scale for DSM-IV PTSD (7-item symptom index, following a trauma-exposure screen)
Time Frame: Baseline, before the intervention; and follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group. Approximately 8 weeks.

The Modified Short Screening Scale for DSM-IV PTSD is a 7-item measure assessing the frequency of posttraumatic stress symptoms following exposure to a traumatic event. Items assess symptom frequency over the preceding four weeks, with responses ranging from 0 (not at all) to 3 (nearly every day). Total scores range from 0 to 21, with higher scores indicating greater symptom frequency.

Baseline, before the intervention; and follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group. Approximately 8 weeks.
Patient Health Questionnaire (PHQ) Anxiety Subscale
Time Frame: Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.

The Patient Health Questionnaire (PHQ) Anxiety Subscale is a 7-item measure assessing the frequency of anxiety symptoms over the preceding four weeks. Items are rated on a 4-point scale from 0 (not at all) to 3 (nearly every day). The total score range is 0-18, with higher scores indicating greater anxiety symptom frequency.

Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.
PHQ-9 Depression Subscale
Time Frame: Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.

The Patient Health Questionnaire-9 (PHQ-9) is a 9-item measure assessing the frequency of depressive symptoms over the preceding two weeks. Items are rated on a 4-point scale from 0 (not at all) to 3 (nearly every day). Total scores range from 0 to 27, with higher scores indicating greater depressive symptom severity.

Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.
TSC-40 composite score.
Time Frame: Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.

The Trauma Symptom Checklist-40 (TSC-40) is a 40-item measure assessing trauma-related symptoms over the preceding two months. Items are rated on a 4-point scale from 0 (never) to 3 (often). The composite score ranges from 0 to 120, with higher scores indicating greater trauma-related distress.

Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.
TSC-40 Anxiety Subscale
Time Frame: Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.

The Anxiety subscale of the Trauma Symptom Checklist-40 (TSC-40) consists of 9 items assessing trauma-related anxiety symptoms over the preceding two months. Items are rated on a 4-point scale from 0 (never) to 3 (often). Total scores range from 0 to 27, with higher scores indicating greater anxiety symptoms.

Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.
TSC-40 Depression Subscale
Time Frame: Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.

The Depression subscale of the Trauma Symptom Checklist-40 (TSC-40) consists of 9 items assessing trauma-related depressive symptoms over the preceding two months. Items are rated on a 4-point scale from 0 (never) to 3 (often). Total scores range from 0 to 27, with higher scores indicating greater depressive symptoms.

Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
TSC-40 Outcome Measures 1. Dissociation Subscale
Time Frame: Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.

The Dissociation subscale of the Trauma Symptom Checklist-40 (TSC-40) consists of 6 items assessing dissociative symptoms over the preceding two months. Items are rated on a 4-point scale from 0 (never) to 3 (often). Total scores range from 0 to 18, with higher scores indicating greater dissociative symptoms.

Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.
TSC-40 Outcome Measures 2. Sexual Abuse Trauma Index (SATI)
Time Frame: Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.

The Sexual Abuse Trauma Index (SATI) of the TSC-40 consists of 7 items assessing symptoms associated with sexual abuse trauma over the preceding two months. Items are rated on a 4-point scale from 0 (never) to 3 (often). Total scores range from 0 to 21, with higher scores indicating greater symptom frequency.

Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.
TSC-40 Outcome Measures 3. Sleep Disturbances Subscale
Time Frame: Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.

The Sleep Disturbances subscale of the TSC-40 consists of 6 items assessing sleep-related difficulties over the preceding two months. Items are rated on a 4-point scale from 0 (never) to 3 (often). Total scores range from 0 to 18, with higher scores indicating greater sleep disturbance.

Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.
Buss-Warren Aggression Questionnaire (AQ)
Time Frame: Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.

A measure of aggressive behavior and tendencies. ET+ uses only the Verbal Aggression and Physical Aggression subscales to assess verbal and physical expressions of aggression.

Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.
Brief Resilient Coping Scale
Time Frame: Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.

A 4-item measure assessing the ability to cope with stress in an adaptive and resilient manner.

Baseline before the intervention; follow-up approximately 2 weeks after completion of the six-session intervention for the treatment group, and at ET+ orientation, before the intervention begins, for the control group.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: NENA P Messina, Envisioning Justice Solutions, Inc

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2026

Primary Completion (Estimated)

June 30, 2028

Study Completion (Estimated)

June 30, 2028

Study Registration Dates

First Submitted

November 13, 2026

First Submitted That Met QC Criteria

November 13, 2026

First Posted (Actual)

November 18, 2026

Study Record Updates

Last Update Posted (Actual)

November 18, 2026

Last Update Submitted That Met QC Criteria

November 13, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be shared because sharing is subject to applicable data-use restrictions and authorization from the California Department of Corrections and Rehabilitation (CDCR).

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe